Want to see CTRE full AI Analyst Report?
CareTrust REIT (CTRE) AI Stock Analysis
CareTrust REIT
(NYSE:CTRE)
CTRE scores well primarily on high-quality financial performance (strong margins and free cash flow) and a bullish earnings call featuring raised guidance and conservative leverage with ample liquidity. Offsetting this is a weaker technical setup with the stock trading below key moving averages and negative MACD, while valuation is supported by the dividend but tempered by a mid-20s P/E.
CareTrust REIT (CTRE) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- $8.67B
- Dividend Yield
- 3.97%
- Average Volume (3M)
- 2.45M
- Price to Earnings (P/E)
- 23.6
- Beta (1Y)
- 0.19
- Revenue Growth
- 53.07%
- EPS Growth
- 32.48%
- Country
- US
- Employees
- 43
- Sector
- Real Estate
- Sector Strength
- 65
- Industry
- REIT - Healthcare Facilities
CareTrust REIT Business Overview & Revenue Model
Company Description
CareTrust REIT, Inc. operates as a self-managed, publicly traded real estate investment trust. The company specializes in the ownership, acquisition, development, and leasing of various healthcare properties, including skilled nursing facilities, sen...
How the Company Makes Money
CareTrust REIT makes money primarily by owning healthcare real estate and leasing it to operating companies that run the underlying care businesses. Its core revenue stream is contractual rent collected from tenants under long-term lease arrangements...
CareTrust REIT Earnings Call Summary
The call was strongly positive on operational and financial performance: record quarterly investments, robust YTD deployment (~$1.5B), double-digit per-share growth guidance, materially higher normalized FFO/FAD and conservative leverage with ample liquidity. Offsetting items are focused and tactical: competitive pressures and cap rate compression in the SHOP market, modest pricing premium on a large U.K. buy, reliance on unsettled equity forward proceeds and certain guidance assumptions, and multi-year uncertainty around financing receivable purchase options. Overall the strengths (record investment activity, significant FFO/FAD growth, strong balance sheet and operator quality) materially outweigh the select execution and market risks discussed.
Q2-2026 Updates
Positive Updates
Negative Updates
Company Guidance
CareTrust raised full-year 2026 guidance, now projecting normalized FFO per share of $2.03–$2.06 and normalized FAD per share of $2.01–$2.04 (midpoint implying ~16.2% FFO/share and ~15.1% FAD/share growth vs. 2025) based on a weighted average diluted share count of 233 million; the outlook assumes no new investments/loans/dispositions or debt/equity issuances beyond year‑to‑date activity, 2.5% inflation-based rent escalators on long‑term triple‑net leases, $147 million of loans to be repaid during the year (≈$104 million received to date), and no material change in GBP/USD. The company noted ample liquidity to fund guidance with roughly $1.4 billion available (≈$90 million cash, $605 million revolver availability on a $1.2 billion facility, ≈$671 million unsettled equity forwards and ≈$785.8 million ATM capacity), a net debt to annualized normalized run‑rate EBITDA of 1.0x, fixed charge coverage of 9.9x, and no scheduled debt maturities before 2028.
CareTrust REIT Financial Statement Overview
Summary
Strong fundamentals supported by accelerating TTM revenue growth (~16%), very high net margins (~65%), and excellent cash generation (TTM FCF $519M; ~97% of net income). Balance-sheet risk appears meaningfully reduced with zero total debt reported in TTM and improved flexibility, though historical earnings volatility (notably 2022) is a key watchout.
Income Statement
86Very PositiveBalance Sheet
88Very PositiveCash Flow
91Very Positive| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 543.45M | 476.59M | 228.26M | 198.60M | 187.51M | 190.19M |
| Gross Profit | 413.20M | 281.79M | 214.71M | 189.01M | 178.13M | 186.62M |
| EBITDA | 523.27M | 462.04M | 211.64M | 145.86M | 72.88M | 151.05M |
| Net Income | 355.40M | 320.54M | 125.08M | 53.73M | -7.51M | 71.98M |
Balance Sheet | ||||||
| Total Assets | 5.93B | 5.15B | 3.44B | 2.08B | 1.62B | 1.64B |
| Cash, Cash Equivalents and Short-Term Investments | 49.27M | 198.04M | 213.82M | 294.45M | 13.18M | 19.89M |
| Total Debt | 1.21B | 894.22M | 396.93M | 595.60M | 719.50M | 673.40M |
| Total Liabilities | 1.42B | 1.09B | 507.63M | 666.12M | 771.41M | 725.09M |
| Stockholders Equity | 4.49B | 4.04B | 2.91B | 1.42B | 849.37M | 915.76M |
Cash Flow | ||||||
| Free Cash Flow | 431.35M | 379.04M | 236.20M | 143.79M | 137.12M | 150.86M |
| Operating Cash Flow | 446.99M | 394.03M | 244.25M | 154.77M | 144.41M | 156.87M |
| Investing Cash Flow | -1.63B | -1.46B | -1.51B | -267.81M | -127.40M | -192.63M |
| Financing Cash Flow | 923.12M | 1.05B | 1.19B | 394.32M | -23.73M | 36.74M |
CareTrust REIT Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CTRE, the sentiment is Neutral. The current price of 37.95 is above the 20-day moving average (MA) of 36.28, above the 50-day MA of 37.20, and below the 200-day MA of 38.33, indicating a neutral trend. The MACD of -0.21 indicates Negative momentum. The RSI at 51.26 is Neutral, neither overbought nor oversold. The STOCH value of 57.65 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for CTRE.
CareTrust REIT Risk Analysis
CareTrust REIT disclosed 50 risk factors in its most recent earnings report. CareTrust REIT reported the most risks in the "Finance & Corporate" category.
Latest Risks Added
1 New RiskCareTrust REIT Peers Comparison
Overall Rating
OHI80Outperform
CTRE80Outperform
LTC75Outperform
SBRA72Outperform
NHI68Neutral
STRW65Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 80Outperform | $14.40B | 19.43 | 14.32% | 5.49% | 14.14% | 37.89% | |
| 80Outperform | $8.67B | 23.57 | 8.54% | 3.97% | 53.07% | 32.48% | |
| 75Outperform | $2.47B | 4.78 | 39.59% | 4.92% | 68.94% | 1200.88% | |
| 72Outperform | $5.33B | 75.32 | 2.55% | 5.69% | 21.20% | -61.51% | |
| 68Neutral | $3.38B | 20.54 | 10.96% | 5.19% | 23.77% | 10.04% | |
| Sector * | 65Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% |
| 65Neutral | $701.19M | 20.44 | 72.36% | 5.05% | 18.27% | 6.18% |
* Real Estate Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| CTRE | CareTrust REIT | 37.95 | 3.79 | 11.08% | |
| LTC | Ltc Properties | 46.33 | 12.85 | 38.39% | |
| NHI | National Health Investors | 71.29 | -0.40 | -0.56% | |
| OHI | Omega Healthcare Investors | 49.17 | 8.33 | 20.38% | |
| SBRA | Sabra Healthcare Reit | 21.09 | 3.34 | 18.85% | |
| STRW | Strawberry Fields REIT Inc | 13.08 | 2.09 | 18.96% |
CareTrust REIT Corporate Events
CareTrust REIT Expands Credit Facility, Boosting Liquidity
PositiveOn October 29, 2026, CareTrust REIT and its operating partnership entered into a fourth amended and restated credit and guaranty agreement, expanding their unsecured credit facility to include a $2.0 billion revolving credit line with multi-currency...
CareTrust REIT expands UK care home portfolio
PositiveOn October 1, 2026, CareTrust REIT, through its UK subsidiary, completed the acquisition of share capital in companies holding 23 completed care homes and one additional home pending regulatory approval from LNT Care Developments for approximately &#...
CareTrust REIT Raises 2026 Guidance After Strong Quarter
PositiveCareTrust REIT reported strong operating results for the quarter ended June 30, 2026, highlighted by net income of $89.0 million, or $0.38 per diluted share, up 9% year over year, and double-digit gains in Normalized FFO and FAD per share to $0.51. T...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Oct 30, 2026